Patents by Inventor David Craeye

David Craeye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250019647
    Abstract: The invention is directed to producing large numbers of cells using hollow fiber bioreactor technology. The cells are non-embryonic stem, non-germ cells that can be characterized by one or more of the following: extended replication in culture and markers of extended replication, such as telomerase, markers of pluripotentiality, and broad differentiation potential, without being transformed.
    Type: Application
    Filed: September 26, 2024
    Publication date: January 16, 2025
    Inventors: Jozef Albert Martha PINXTEREN, David CRAEYE
  • Publication number: 20250002856
    Abstract: One embodiment of the invention provides culture-expanded canine progenitor cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. The culture-expanded cells are post-natal somatic cells that can be characterized by one or more of the following: a population doubling rate of less than about 24 hours; a normal karyotype; can differentiate into at least two cell types of the mesodermal germ layer; extended replication in culture and express markers of extended replication, such as telomerase; and express markers of pluripotency. Also provided are methods of isolation and culture as well as therapeutic uses for the cells, such as treating musculoskeletal and inflammatory diseases and disorders. Additionally provided are cell banks that can be used to provide the cells for administration to a subject, drug discovery methods, and compositions of cells, such as in pharmaceutical compositions.
    Type: Application
    Filed: November 4, 2022
    Publication date: January 2, 2025
    Inventors: Robert J. DEANS, Annelies BOGAERTS, David CRAEYE
  • Publication number: 20170022472
    Abstract: The invention is directed to producing large numbers of cells using hollow fiber bioreactor technology. The cells are non-embryonic stem, non-germ cells that can be characterized by one or more of the following: extended replication in culture and markers of extended replication, such as telomerase, markers of pluripotentiality, and broad differentiation potential, without being transformed.
    Type: Application
    Filed: September 16, 2016
    Publication date: January 26, 2017
    Applicant: ReGenesys BVBA
    Inventors: Jozef Albert Martha PINXTEREN, David CRAEYE
  • Publication number: 20120308531
    Abstract: The invention is directed to producing large numbers of cells using hollow fiber bioreactor technology. The cells are non-embryonic stem, non-germ cells that can be characterized by one or more of the following: extended replication in culture and markers of extended replication, such as telomerase, markers of pluripotentiality, and broad differentiation potential, without being transformed.
    Type: Application
    Filed: June 6, 2012
    Publication date: December 6, 2012
    Applicant: ReGenesys BVBA
    Inventors: Jozef Albert Martha Pinxteren, David Craeye